BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28797895)

  • 1. Patterns of C-reactive protein ratio predicts outcomes in healthcare-associated pneumonia in critically ill patients with cancer.
    Rabello LSCF; Póvoa P; Lapa E Silva JR; Azevedo LCP; da Silva Ramos FJ; Lisboa T; Soares M; Salluh JIF
    J Crit Care; 2017 Dec; 42():231-237. PubMed ID: 28797895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of C-reactive protein ratio response to antibiotics in pediatric sepsis: A prospective cohort study.
    Lanziotti VS; Póvoa P; Prata-Barbosa A; Pulcheri LB; Rabello LSCF; Lapa E Silva JR; Soares M; Salluh JIF
    J Crit Care; 2018 Apr; 44():217-222. PubMed ID: 29161668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study.
    Coelho LM; Salluh JI; Soares M; Bozza FA; Verdeal JC; Castro-Faria-Neto HC; Lapa e Silva JR; Bozza PT; Póvoa P
    Crit Care; 2012 Dec; 16(2):R53. PubMed ID: 22449513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock.
    Ryu JA; Yang JH; Lee D; Park CM; Suh GY; Jeon K; Cho J; Baek SY; Carriere KC; Chung CR
    PLoS One; 2015; 10(9):e0138150. PubMed ID: 26367532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study.
    Póvoa P; Coelho L; Almeida E; Fernandes A; Mealha R; Moreira P; Sabino H
    Eur Respir J; 2005 May; 25(5):804-12. PubMed ID: 15863636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia.
    Póvoa P; Souza-Dantas VC; Soares M; Salluh JF
    Crit Care; 2011; 15(3):R129. PubMed ID: 21595932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes and microbiological characteristics of severe pneumonia in cancer patients: a prospective cohort study.
    Rabello LS; Silva JR; Azevedo LC; Souza I; Torres VB; Rosolem MM; Lisboa T; Soares M; Salluh JI
    PLoS One; 2015; 10(3):e0120544. PubMed ID: 25803690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in procalcitonin level and outcome in critically ill children with severe sepsis/septic shock-A pilot study.
    Poddar B; Gurjar M; Singh S; Aggarwal A; Baronia A
    J Crit Care; 2016 Dec; 36():230-233. PubMed ID: 27566963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia.
    Hillas G; Vassilakopoulos T; Plantza P; Rasidakis A; Bakakos P
    Eur Respir J; 2010 Apr; 35(4):805-11. PubMed ID: 19717486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study.
    Póvoa P; Teixeira-Pinto AM; Carneiro AH;
    Crit Care; 2011 Jul; 15(4):R169. PubMed ID: 21762483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Hill AT
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients.
    Ranzani OT; Zampieri FG; Forte DN; Azevedo LC; Park M
    PLoS One; 2013; 8(3):e59321. PubMed ID: 23555017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
    Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
    J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
    Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
    Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.
    Attridge RT; Frei CR; Pugh MJ; Lawson KA; Ryan L; Anzueto A; Metersky ML; Restrepo MI; Mortensen EM
    J Crit Care; 2016 Dec; 36():265-271. PubMed ID: 27595461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of delirium in critically ill patients with elevated C-reactive protein.
    Zhang Z; Pan L; Deng H; Ni H; Xu X
    J Crit Care; 2014 Feb; 29(1):88-92. PubMed ID: 24120090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of Early C-Reactive Protein Kinetics in Response and Prognostic Assessment in Infected Critically Ill Patients: An Observational Retrospective Study.
    Pereira MA; Rouxinol-Dias AL; Vieira T; Paiva JA; Pereira JM
    Acta Med Port; 2019 Dec; 32(12):737-745. PubMed ID: 31851882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multicenter, Prospective, Observational Study to Determine Predictive Factors for Multidrug-Resistant Pneumonia in Critically Ill Adults: The DEFINE Study.
    Lat I; Daley MJ; Shewale A; Pangrazzi MH; Hammond D; Olsen KM;
    Pharmacotherapy; 2019 Mar; 39(3):253-260. PubMed ID: 30101412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.